US Stocks That May Be Trading Below Estimated Value In October 2024

Simply Wall St.10-31

As the U.S. stock market experiences a downturn amid anticipation of major tech earnings and mixed economic signals, investors are keenly observing opportunities that may arise from this volatility. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2479800705?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/nzKrm42FSn6V71xz6p35kw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a49a47a9f32b0da2b60e02ee1083081b","is_english":true,"pubTime":"2024-10-31 18:05","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2479800705","market":"us","top_or_hot":-1,"title":"US Stocks That May Be Trading Below Estimated Value In October 2024","media":"Simply Wall St.","content":"<div>\n<p>As the U.S. stock market experiences a downturn amid anticipation of major tech earnings and mixed economic signals, investors are keenly observing opportunities that may arise from this volatility. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-may-trading-below-100510273.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US Stocks That May Be Trading Below Estimated Value In October 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS Stocks That May Be Trading Below Estimated Value In October 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-31 18:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-may-trading-below-100510273.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As the U.S. stock market experiences a downturn amid anticipation of major tech earnings and mixed economic signals, investors are keenly observing opportunities that may arise from this volatility. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-may-trading-below-100510273.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B2B36J28.USD","symbol_name":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","start_time":0,"source_url":"https://finance.yahoo.com/news/us-stocks-may-trading-below-100510273.html","article_id":"2479800705","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/nzKrm42FSn6V71xz6p35kw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a49a47a9f32b0da2b60e02ee1083081b"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479800705","pubTimestamp":1730369110,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"As the U.S. stock market experiences a downturn amid anticipation of major tech earnings and mixed economic signals, investors are keenly observing opportunities that may arise from this volatility. In such an environment, identifying stocks that might be trading below their estimated value can offer potential for long-term growth, making them attractive to those looking to capitalize on market fluctuations.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Vertex Pharmaceuticals is trading at a significant discount, approximately 44.3% below its estimated fair value of US$852.9, based on discounted cash flow analysis. Recent updates in their kidney disease pipeline, including positive data for povetacicept in IgA nephropathy and primary membranous nephropathy, highlight potential revenue drivers. Despite reporting losses recently, Vertex has raised its full-year revenue guidance to US$10.65 billion-US$10.85 billion, reflecting confidence in its product portfolio expan","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","WAL":"阿莱恩斯西部银行","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2249611893.SGD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (SGD) ACC","LU2357125470.USD":"BNP PARIBAS ENERGY TRANSITION \"CLASSIC RH\" (USDHDG) ACC","LU2506951792.HKD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (HKDHDG)       ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","LU1861220207.SGD":"Blackrock FinTech A2 SGD-H","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","CRC":"加州资源","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU0266512127.USD":"摩根大通环球自然资源 A(acc)","IE00BMPRXQ63.HKD":"NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND \"A\" (HKDHDG) ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU0456854461.SGD":"JPMorgan Funds - Global Natural Resources A (acc) SGD","VRTX":"福泰制药","VERX":"Vertex, Inc.","BK4106":"数据处理与外包服务","WEX":"Wex Inc","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","BK4532":"文艺复兴科技持仓","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","BK4571":"数字音乐概念","BK4108":"电影和娱乐","BK4585":"ETF&股票定投概念","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","PFS":"Provident Financial Services Inc","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4227":"交易和支付处理服务","VRT":"Vertiv Holdings LLC","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","SPOT":"Spotify Technology S.A.","LU2360107168.USD":"BGF NEXT GENERATION TECHNOLOGY \"A4\" (USD) INC","VTS":"Vitesse Energy","LU2290526834.HKD":"BGF NEXT GENERATION TECHNOLOGY \"A2\" (HKDHDG) ACC"},"translate_title":"2024年10月交易价格可能低于预期价值的美国股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WEX":1,"PFS":1,"SPOT":1,"CRC":1,"VRT":1,"VTS":1,"WAL":1,"VRTX":0.9,"VERX":0.9},"content_text":"As the U.S. stock market experiences a downturn amid anticipation of major tech earnings and mixed economic signals, investors are keenly observing opportunities that may arise from this volatility. In such an environment, identifying stocks that might be trading below their estimated value can offer potential for long-term growth, making them attractive to those looking to capitalize on market fluctuations.\nTop 10 Undervalued Stocks Based On Cash Flows In The United States\n\n\n\nName\nCurrent Price\nFair Value (Est)\nDiscount (Est)\n\n\nProvident Financial Services (NYSE:PFS)\n$19.03\n$37.92\n49.8%\n\n\nWestern Alliance Bancorporation (NYSE:WAL)\n$84.27\n$168.24\n49.9%\n\n\nBank of Marin Bancorp (NasdaqCM:BMRC)\n$22.73\n$44.35\n48.7%\n\n\nCalifornia Resources (NYSE:CRC)\n$52.32\n$104.35\n49.9%\n\n\nUFP Technologies (NasdaqCM:UFPT)\n$274.00\n$537.57\n49%\n\n\nWEX (NYSE:WEX)\n$173.76\n$343.51\n49.4%\n\n\nVitesse Energy (NYSE:VTS)\n$25.12\n$49.46\n49.2%\n\n\nChromaDex (NasdaqCM:CDXC)\n$3.58\n$7.15\n49.9%\n\n\nAeroVironment (NasdaqGS:AVAV)\n$216.60\n$419.13\n48.3%\n\n\nRapid7 (NasdaqGM:RPD)\n$41.30\n$81.71\n49.5%\n\n\n\nClick here to see the full list of 193 stocks from our Undervalued US Stocks Based On Cash Flows screener.\nLet's review some notable picks from our screened stocks.\nVertex Pharmaceuticals\nOverview: Vertex Pharmaceuticals Incorporated is a biotechnology company focused on developing and commercializing therapies for treating cystic fibrosis, with a market cap of approximately $121.40 billion.\nOperations: The company generates its revenue primarily from its Pharmaceuticals segment, which amounted to $10.34 billion.\nEstimated Discount To Fair Value: 44.3%\nVertex Pharmaceuticals is trading at a significant discount, approximately 44.3% below its estimated fair value of US$852.9, based on discounted cash flow analysis. Recent updates in their kidney disease pipeline, including positive data for povetacicept in IgA nephropathy and primary membranous nephropathy, highlight potential revenue drivers. Despite reporting losses recently, Vertex has raised its full-year revenue guidance to US$10.65 billion-US$10.85 billion, reflecting confidence in its product portfolio expansion and future profitability prospects.\n\nOur growth report here indicates Vertex Pharmaceuticals may be poised for an improving outlook.\nGet an in-depth perspective on Vertex Pharmaceuticals' balance sheet by reading our health report here.\n\n\n\n\n  NasdaqGS:VRTX Discounted Cash Flow as at Oct 2024\n \n\nSpotify Technology\nOverview: Spotify Technology S.A., along with its subsidiaries, offers audio streaming subscription services globally and has a market cap of approximately $78.56 billion.\nOperations: Spotify Technology S.A. generates its revenue through two main segments: Premium, which accounts for €12.68 billion, and Ad-Supported, contributing €1.79 billion.\nEstimated Discount To Fair Value: 13.5%\nSpotify Technology is trading at US$394.02, below its estimated fair value of US$455.43, reflecting a 13.5% discount according to discounted cash flow analysis. Despite recent shareholder dilution and large one-off items impacting earnings quality, Spotify has become profitable this year with earnings expected to grow significantly over the next three years at 31.1% annually—outpacing both revenue growth and the broader US market's profit expansion rate.\n\nOur comprehensive growth report raises the possibility that Spotify Technology is poised for substantial financial growth.\nUnlock comprehensive insights into our analysis of Spotify Technology stock in this financial health report.\n\n\n\n\n  NYSE:SPOT Discounted Cash Flow as at Oct 2024\n \n\nVertiv Holdings Co\nOverview: Vertiv Holdings Co designs, manufactures, and services critical digital infrastructure technologies and life cycle services for data centers, communication networks, and commercial and industrial environments globally, with a market cap of approximately $42.72 billion.\nOperations: The company's revenue segments include $4.30 billion from the Americas, $1.74 billion from the Asia Pacific, and $2.13 billion from Europe, the Middle East, and Africa.\nEstimated Discount To Fair Value: 26.9%\nVertiv Holdings Co is trading at US$112.45, significantly below its estimated fair value of US$153.80, implying it's highly undervalued based on cash flow analysis. Despite a high debt level, Vertiv has demonstrated robust earnings growth of 128.7% over the past year and is forecasted to continue growing at 30.8% annually—surpassing both revenue growth and the broader US market's profit expansion rate—supported by strategic M&A activities and innovative product developments in AI infrastructure solutions.\n\nThe analysis detailed in our Vertiv Holdings Co growth report hints at robust future financial performance.\nClick here and access our complete balance sheet health report to understand the dynamics of Vertiv Holdings Co.\n\n\n\n\n  NYSE:VRT Discounted Cash Flow as at Oct 2024\n \n\nNext Steps\n\nExplore the 193 names from our Undervalued US Stocks Based On Cash Flows screener here.\nInvested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.\nSimply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.\n\nLooking For Alternative Opportunities?\n\nExplore high-performing small cap companies that haven't yet garnered significant analyst attention.\nDiversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.\nFuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.\n\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nCompanies discussed in this article include NasdaqGS:VRTX NYSE:SPOT and NYSE:VRT.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479800705"}